High flow nasal cannula Market Forecast Insights: The Road To $9.64 Billion By 2030
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
High flow nasal cannula Market Size Forecast: How Big Could The Market Get By 2030?
The high flow nasal cannula market has experienced robust expansion in recent years. Its valuation is projected to increase from $6.22 billion in 2025 to $6.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. Historically, this market growth has been propelled by factors such as the increasing incidence of respiratory disorders, a rise in hospital admissions for acute respiratory failure, the implementation of high-flow oxygen therapy protocols, the expansion of intensive care infrastructure, and heightened clinical awareness regarding the benefits of HFNC.
The high flow nasal cannula market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $9.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This projected growth throughout the forecast period stems from several factors, including the expanding application of HFNC in home care environments, a heightened demand for portable respiratory support equipment, the broadening scope of respiratory care provisions, an increasing emphasis on early intervention treatments, and continuous technological progress in airflow and humidification technologies. Key trends during this period encompass the wider integration of sophisticated heated humidification systems, a surge in HFNC utilization within acute care facilities, a developing preference for non-invasive oxygen delivery methods, the proliferation of portable and home-centric HFNC options, and a heightened prioritization of patient comfort and adherence.
Get A Free Sample Report With In-Depth Market Insights:
High flow nasal cannula Market Growth Backed By Core Demand Fundamentals
The growing occurrence of asthma and chronic obstructive pulmonary disease (COPD) is anticipated to boost the expansion of the high-flow nasal cannula market in the future. Asthma is characterized by the narrowing and swelling of lung airways, accompanied by excessive mucus production, while chronic obstructive pulmonary disease (COPD) encompasses a group of pulmonary conditions that progressively impair breathing. A high-flow nasal cannula can elevate PO2 levels, concurrently reducing heart rate (HR) and respiratory rate (RR), making it a suitable therapeutic choice for those with severe bronchial asthma complicated by respiratory failure. This device aids in managing the increasing instances of asthma and COPD by enhancing oxygenation and alleviating respiratory distress in patients. For example, a research study featured in JAMA Network Open, a medical journal from the American Medical Association, in December 2023, projected that the global prevalence of chronic obstructive pulmonary disease (COPD) cases could escalate to nearly 600 million worldwide by 2050, representing a 23% rise in its occurrence. Consequently, the growing frequency of asthma and chronic obstructive pulmonary disease (COPD) cases is propelling the high-flow nasal cannula market.
High flow nasal cannula Market Segmentation And Category Overview
The high flow nasal cannula market covered in this report is segmented –
1) By Type: Air Or Oxygen Blenders, Nasal Cannulas, Active Humidifier, Single Heated Tube, Other Types
2) By Application: Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Carbon Monoxide Toxicity, Bronchiectasis, Sleep Apnea, Other Applications
3) By Sales Channel: Direct Channel, Distribution Channel
4) By End-User: Hospitals and clinics, Ambulatory care centers, Long-term care centers, Other End-Users
Subsegments:
1) By Air or Oxygen Blenders: Manual Oxygen Blenders, Digital Oxygen Blenders
2) By Nasal Cannulas: Adult Nasal Cannulas, Pediatric Nasal Cannulas
3) By Active Humidifier: Heated Active Humidifiers, Non-Heated Active Humidifiers
4) By Single Heated Tube: Single Heated Tubes For Adult Use, Single Heated Tubes For Pediatric Use
5) By Other Types: Disposable High Flow Nasal Cannulas, Non-Invasive Ventilation (NIV) Interfaces
High flow nasal cannula Market Growth Trends Reshaping The Competitive Landscape
Major corporations operating in the high-flow nasal cannula market are directing their efforts toward advanced products, such as the SoftFlow High-Flow Nasal Cannula, to cater to their existing clientele. The SoftFlow High-Flow Nasal Cannula is a respiratory support tool that delivers warm, humidified, oxygen-enriched oxygen to patients via a nasal cannula. For example, in 2024, Fisher & Paykel Healthcare, a New Zealand-based company known for manufacturing and marketing products for acute and chronic respiratory care, surgery, and obstructive sleep apnea, introduced the Airvo 2 device. This device is a component of the Optiflow Nasal High Flow Therapy system. The Airvo 2 provides heated, humidified air and oxygen at high flow rates, which aids in improving oxygenation and decreasing the breathing effort for individuals with COVID-19 and other respiratory conditions. Its optimal humidity levels help maintain mucociliary function and reduce airway dryness, thereby enhancing patient comfort. Moreover, the device is simple to set up and operate, making it adaptable for various hospital settings and contributing to improved clinical outcomes.
High flow nasal cannula Market Industry Leaders And Competitive Landscape
Major companies operating in the high flow nasal cannula market are Air Liquide Medical Systems Pvt. Ltd., Becton Dickinson and Company, Koninklijke Philips N.V., ResMed Inc., Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Medical Dynamics Inc., Fisher & Paykel Healthcare Corporation Limited, Smiths Medical Inc., Vyaire Medical Inc., DeVilbiss Healthcare LLC, Armstrong Medical Ltd, Vapotherm Inc., SunMed LLC, Medin Medical Innovations GmbH, MEK-ICS Co. Ltd., Narang Medical Limited, Breas Medical AB, Bio-Med Devices Inc., Flexicare Medical Ltd., Fairmont Medical Products Pty Ltd, Besmed Health Business Corp., Löwenstein GmbH & Co. KG, Great Group Medical Co. Ltd., TNI Medical AG, Guangdong Pigeon Medical Apparatus Co.LTD, BLS Systems Limited
View The Full High flow nasal cannula Market Report:
High flow nasal cannula Market Regional Analysis And Top Geography
North America was the largest region in the high flow nasal cannula market in 2025. The regions covered in the high flow nasal cannula market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
